RapidTrials focuses exclusively on optimizing the efficiency, quality, and compliance of clinical research sites. We deliver value-added tools and services to sites throughout the clinical trial process. Our intimate understanding of the obstacles that can impede the progress of study collaborations is the result of our hands-on approach to helping sites fulfill study responsibilities.
Tracy Harmon Blumenfeld – Co-founder, President and Chief Executive Officer
RapidTrials, a pharmaceutical service provider, is a leader in improving the efficiency of clinical trials for drug development firms and medical research sites. The Company’s clients include global biopharmaceutical companies and medical research centers. Under Ms. Blumenfeld’s leadership, RapidTrials has been selected as a member of the Philadelphia 100, a distinction conferred on the 100 fastest growing, privately held companies in the greater Philadelphia region. The Philadelphia 100 program is run by the Wharton Small Business Development Center, the Entrepreneurs’ Forum of Greater Philadelphia, and the Philadelphia Business Journal.
Ms. Blumenfeld has published and contributed to numerous articles on site selection, site performance, and study economics in journals such as Pharmaceutical Executive, the Group Practice Journal of the American Medical Association, and The Monitor, a peer-reviewed journal of the Association of Clinical Research Professionals. She has presented to industry and university researchers at conferences convened by the Drug Information Association, the National Institutes of Health, the Association for the Accreditation of Human Research Protection Programs, Inc., and the Harvard Global Health Institute’s Multi-Regional Clinical Trials (MRCT) Center. She has been a guest lecturer on entrepreneurship at Princeton University and clinical trials for the joint Brandeis and Tufts University MD/MBA program. She has recently been awarded a patent for the development of clinical trial software. Ms. Blumenfeld has served as an expert witness. for clinical trial disputes.
Ms. Blumenfeld is a member of the Board of Directors and Secretary for the Mental Health Association of Southeastern Pennsylvania, a Co-Chair of the Site Accreditation Standards Initiative Project Steering Committee of the Alliance for Clinical Research Excellence and Safety, and a Senior Advisor at the Wharton Small Business Development Center,.
Prior to founding RapidTrials, Ms. Blumenfeld served as a Principal for the Consulting and Productivity Products Group, at Parexel International, a contract research organization. At Parexel, she was responsible for designing the industry’s first metrics-based approach for comparing R and D efficiency and performance across leading pharmaceutical companies worldwide. Earlier in her career, she worked as the Director of Marketing and in Business Development for RehabClinics a corporate health care company that provided physical and occupational rehabilitation services at hundreds of outpatient throughout the US; as an Associate at Booz Allen and Hamilton’s Pharmaceutical Strategy Practice; and as a Senior Consultant in the Baxter Management Services Division at Baxter health care Corporation.
Ms. Blumenfeld has a BA degree in Economics from Northwestern University and a Masters of Business Administration from Harvard Business School
Wolffe Nadoolman, MD MBA – Medical Director/Co-founder
With experience as a practicing primary care physician as well as a researcher, Dr. Nadoolman has published numerous papers and has been awarded a patent, with others pending. Formerly an executive at Salomon Brothers, he has helped start several companies. As a consultant, he analyzed productivity in clinical trials. Dr. Nadoolman has also just recently founded Private Pediatrics, Inc. in Berkeley, CA. He holds a medical degree from Yale University School of Medicine, a Masters of Business Administration from Harvard Business School and a Bachelors Degree from Cornell University. He is an Expert Medical Reviewer for the Medical Board of the State of California, is a former Institutional Review Board member, and a diplomat of relevant training by the NIH Office of Human Subjects Research and in Bioethics by the Kennedy School of Ethics at Georgetown University. Dr. Nadoolman has worked as a consultant to Pfizer Inc. and has participated in a Pfizer Roundtable, published in The Pfizer Journal, on health care Quality.
Claude Nash, Ph.D.
• Board of Directors of Adolor
• Board of Directors of Selectx Pharmaceutical
• Chairman and CEO of Accera
• Founder ViroPharma Incorporated
• Vice President at Schering Plough Research Institute.
• BS degree in Biology and a Ph. D. and MS degree in microbiology
Linda A. Barnes Meyerson, R.Ph
• Retired COO for ICON
• President of Global Clinical Operations at GlaxoSmithKline.
• Serviced in a variety of leadership positions with the Janssen Research Foundation and the RW Johnson Pharmaceutical Research Institute.
Alan Vinick, JD, MBA
• Retired CFO at TMG Health, a Business Process Outsourcing (BPO) service provider to the Medicare, Medicaid and retiree health plan markets
• Chief Financial Officer Apogee, Inc., RehabClinics, Inc., Orthopedic Services, Inc., Heritage Health Systems, Inc., and John Hancock Health Plans, Inc.
• Officer of CIGNA Corporation
• Secretary to the Emergency Loan Guarantee Board
• JD from the Columbus School of Law, an MBA from the University of Massachusetts, and a BS from Babson College